|
GORAB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.807400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.810000E-01 |
| Normal-vs-Stage2 |
2.837800E-01 |
| Normal-vs-Stage3 |
2.371400E-01 |
| Normal-vs-Stage4 |
5.862200E-02 |
| Stage1-vs-Stage2 |
2.452400E-01 |
| Stage1-vs-Stage3 |
1.777190E-01 |
| Stage1-vs-Stage4 |
2.034500E-02 |
| Stage2-vs-Stage3 |
9.001400E-01 |
| Stage2-vs-Stage4 |
6.920600E-01 |
| Stage3-vs-Stage4 |
5.333200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.962200E-01 |
| Normal-vs-AfricanAmerican |
9.231600E-01 |
| Normal-vs-Asian |
1.366300E-02 |
| Caucasian-vs-AfricanAmerican |
4.314800E-01 |
| Caucasian-vs-Asian |
1.288410E-01 |
| AfricanAmerican-vs-Asian |
3.939700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.756200E-01 |
| Normal-vs-Female |
2.452600E-01 |
| Male-vs-Female |
7.022600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.176000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.509800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.561600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.366200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.690000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.316800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.706400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.885800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.333600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.817000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.832800E-01 |
| Normal-vs-Grade 2 |
4.919600E-01 |
| Normal-vs-Grade 3 |
5.266400E-01 |
| Normal-vs-Grade 4 |
8.005800E-02 |
| Grade 1-vs-Grade 2 |
6.931000E-01 |
| Grade 1-vs-Grade 3 |
6.899200E-01 |
| Grade 1-vs-Grade 4 |
6.607800E-01 |
| Grade 2-vs-Grade 3 |
9.689600E-01 |
| Grade 2-vs-Grade 4 |
1.388620E-01 |
| Grade 3-vs-Grade 4 |
1.445020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.621000E-01 |
| Normal-vs-ccB subtype |
3.565600E-01 |
| ccA subtype-vs-ccB subtype |
9.868800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.575760E-01 |
| Normal-vs-N1 |
1.411010E-01 |
| N0-vs-N1 |
1.944810E-01 |
|
|
